ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

Panel To Hear Centers’ Problems Again; Alabama, Mayo Impress Site visitors

March 18, 1977

Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI

March 1, 1985